Genedrive PLC


Genedrive PLC

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)36.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-42.40%
  • Beta-0.0987
Data delayed at least 20 minutes, as of Sep 18 2017 13:07 BST.
More ▼

Key statistics

On Monday, Genedrive PLC (GDR:LSE) closed at 36.00, 20.00% above the 52 week low of 30.00 set on Feb 03, 2017.
52-week range
30.00Feb 03 201765.00Dec 14 2016
Previous close36.00
Average volume47.01k
Shares outstanding18.69m
Free float14.05m
P/E (TTM)--
Market cap6.73m GBP
EPS (TTM)-0.391
Data delayed at least 20 minutes, as of Sep 18 2017 13:07 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Genedrive PLC shares was Hold at 288.00 on 28 Oct 2014Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.